Bank of New York Mellon Corp

Bank

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 1390777 NEW YORK, NY

Position in GLSI

as of Mar 31, 2026 · filed May 5, 2026 Compact

Position Value

$1,117,480

+$826,157 QoQ

Shares Held

46,523

+235.5% QoQ

Ownership

0.317%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

Bank of New York Mellon Corp holds $4,203,725,512 across 270 Biotechnology names. GLSI ranks #167 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,586,427	$708,403,098
2	REGN	Regeneron Pharmaceuticals, Inc.	765,411	$591,387,145
3	JAZZ	Jazz Pharmaceuticals plc	1,679,371	$317,485,079
4	INSM	INSMED Inc	1,262,749	$206,484,708
5	ALNY	Alnylam Pharmaceuticals, Inc.	491,200	$162,523,337
6	INCY	Incyte Corp	989,709	$93,151,403
7	TECH	BIO-TECHNE Corp	1,759,119	$91,931,549
8	MRNA	Moderna, Inc.	1,691,205	$85,913,207

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,117,480	46,523	+235.5%	Shares	Defined	2026-05-05
2025-12-31	$291,323	13,866	-8.3%	Shares	Defined	2026-02-10
2025-09-30	$150,521	15,128	+3.6%	Shares	Defined	2025-11-03
2025-06-30	$132,384	14,596	+30.3%	Shares	Defined	2025-08-05
2025-03-31	$106,876	11,203	0.0%	Shares	Defined	2025-04-29
2024-12-31	$125,808	11,203	0.0%	Shares	Defined	2025-02-04
2024-09-30	$160,986	11,203	-26.8%	Shares	Defined	2024-11-12
2024-06-30	$263,991	15,295	+51.2%	Shares	Defined	2024-07-25
2022-03-31	$198,435	10,114	0.0%	Shares	Defined	2022-05-11
2021-12-31	$246,072	10,114	+1.8%	Shares	Defined	2022-02-11
2021-09-30	$388,081	9,933	+49.1%	Shares	Defined	2021-11-18
2021-06-30	$299,479	6,664	—	Shares	Defined	2021-08-11
No filing history on record for this holder in this stock.